Transudates in Malignancy: Still a Role for Pleural Fluid

dc.authoridGonlugur, Ugur/0000-0001-8720-2788
dc.contributor.authorGonlugur, Tanseli E.
dc.contributor.authorGonlugur, Ugur
dc.date.accessioned2025-01-27T20:27:14Z
dc.date.available2025-01-27T20:27:14Z
dc.date.issued2008
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractIntroduction: The aims of this study were to determine the distribution of transudates and exudates among pathologically proven malignant pleural effusions, and to demonstrate the necessity for cytologic studies in patients with a transudative effusion. Materials and Methods: This study is a retrospective review of all subjects diagnosed with malignant or paramalignant pleural effusion over a 10-year period at a tertiary hospital. The study included 67 subjects with malignant mesothelioma, 45 subjects with metastatic disease,and 36 subjects with paramalignant effusions. Results: There were 55 female and 93 male subjects; the mean age of the sample was 62 years. Malignant pleural effusions were transudative in 1.5% of malignant mesotheliomas, 6.8% of metastatic diseases, and 11.1% of paramalignant effusions. Conclusions: Cytological examination of pleural fluid in patients with unexplained transudative effusion is essential to rule out malignant processes.
dc.identifier.endpage763
dc.identifier.issn0304-4602
dc.identifier.issue9
dc.identifier.pmid18989492
dc.identifier.scopus2-s2.0-55549145147
dc.identifier.scopusqualityQ1
dc.identifier.startpage760
dc.identifier.urihttps://hdl.handle.net/20.500.12428/22629
dc.identifier.volume37
dc.identifier.wosWOS:000261822300007
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherAcad Medicine Singapore
dc.relation.ispartofAnnals Academy of Medicine Singapore
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectBiochemical criteria
dc.subjectPleural malignancy
dc.subjectPleural neoplasms
dc.titleTransudates in Malignancy: Still a Role for Pleural Fluid
dc.typeArticle

Dosyalar